Literature DB >> 23483448

Association between neurotensin receptor 1 (NTR1) gene polymorphisms and schizophrenia in a Han Chinese population.

Hui Ma1, Yinglin Huang, Bo Zhang, Jingying Li, Yuan Wang, Xiaofeng Zhao, Qiu Jin, Gang Zhu.   

Abstract

Neurotensin (NT) is a multifunctional gut hormone, neurotransmitter, and neuromodulator that triggers many physiological responses by binding to the high-affinity neurotensin receptor 1 (NTR1). Previous studies have implicated the roles of NT and NTR1 in the etiology or expression of schizophrenia. This case-control study examined the associations between schizophrenia and three NTR1 gene polymorphisms (rs6090453C/G, rs6011914C/G, and rs2427422A/G) previously linked to working memory performance in a Han Chinese population. These three polymorphisms were genotyped in 390 schizophrenic patients and 565 healthy subjects. Compared with those of the controls, the frequencies for C allele in the rs6090453C/G polymorphism were higher in the schizophrenic patients (p = 0.049) and their female subgroup (p = 0.014). The frequencies for the rs6090453C/rs6011914G/rs2427422G (CGG) haplotype were also higher in the patients (p = 0.016) and their female subgroup (p = 0.005). Moreover, in the female subgroup, the frequencies for the rs6090453G/rs6011914C/rs2427422G (GCG) haplotype were higher in the controls (p = 0.028). Our results suggest that the C allele (CC or CG genotype) in the rs6090453C/G polymorphism and the CGG haplotype may enhance schizophrenia susceptibility in the Han Chinese population, while the GCG haplotype may be a protective factor, particularly in females.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483448     DOI: 10.1007/s12031-013-9988-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.

Authors:  Anne Remaury; Natalio Vita; Sylvain Gendreau; Mireille Jung; Michelle Arnone; Martine Poncelet; Jean-Michel Culouscou; Gérard Le Fur; Philippe Soubrié; Daniel Caput; David Shire; Manfred Kopf; Pascual Ferrara
Journal:  Brain Res       Date:  2002-10-25       Impact factor: 3.252

2.  Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese.

Authors:  Fanglin Guan; Chen Zhang; Shuguang Wei; Hongbo Zhang; Xiaomin Gong; Jiali Feng; Chengge Gao; Rong Su; Huanming Yang; Shengbin Li
Journal:  Hum Genet       Date:  2011-12-11       Impact factor: 4.132

3.  An association study of the neurotensin receptor gene with schizophrenia and clozapine response.

Authors:  P Huezo-Diaz; M J Arranz; J Munro; S Osborne; A Makoff; R W Kerwin; J Austin; M O'Donovan
Journal:  Schizophr Res       Date:  2004-02-01       Impact factor: 4.939

4.  Comparative sequencing of the proneurotensin gene and association studies in schizophrenia.

Authors:  J Austin; B Hoogendoorn; P Buckland; G Speight; A Cardno; T Bowen; N Williams; G Spurlock; R Sanders; L Jones; K Murphy; G McCarthy; P McGuffin; M J Owen; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

5.  The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia.

Authors:  J Austin; P Buckland; A G Cardno; N Williams; G Spurlock; B Hoogendoorn; S Zammit; G Jones; R Sanders; L Jones; G McCarthy; S Jones; N J Bray; P McGuffin; M J Owen; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2000-09       Impact factor: 15.992

6.  [3H]Neurotensin receptor densities in human postmortem brain tissue obtained from normal and schizophrenic persons. An autoradiographic study.

Authors:  R A Lahti; E V Cochrane; R C Roberts; R R Conley; C A Tamminga
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

7.  Chronic neuroleptic treatment enhances neurotensin receptor binding in human and rat substantia nigra.

Authors:  G R Uhl; M J Kuhar
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

8.  Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin.

Authors:  P Kitabgi; R Carraway; S E Leeman
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

9.  Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.

Authors:  Jordan A Mechanic; Janette E Sutton; Amy E Berson; Xiaosu Wu; Joyce Kwan; Rudy Schreiber; Zhen Pang; Donald C Button
Journal:  Eur Neuropsychopharmacol       Date:  2009-02-14       Impact factor: 4.600

10.  CSF concentrations of neurotensin in schizophrenia: an investigation of clinical and biochemical correlates.

Authors:  N A Breslin; R L Suddath; G Bissette; C B Nemeroff; P Lowrimore; D R Weinberger
Journal:  Schizophr Res       Date:  1994-04       Impact factor: 4.939

View more
  4 in total

1.  Association of Neurotensin receptor 1 gene polymorphisms with processing speed in healthy Chinese-Han subjects.

Authors:  Man Wang; Hui Ma; Ying-lin Huang; Gang Zhu; Jing-ping Zhao
Journal:  J Mol Neurosci       Date:  2014-08-27       Impact factor: 3.444

2.  Association between neurotensin receptor 1 gene polymorphisms and alcohol dependence in a male Han Chinese population.

Authors:  Hui Ma; Yinglin Huang; Bo Zhang; Yuan Wang; Hong Zhao; Hong Du; Zhengtu Cong; Jingying Li; Gang Zhu
Journal:  J Mol Neurosci       Date:  2013-06-08       Impact factor: 3.444

3.  Association of nitric oxide synthase 1 adaptor protein gene polymorphisms with schizophrenia in a Chinese Han population.

Authors:  Xueping Yang; Jing Zhou; Zhen Yuan; Ailu Lin; Xin Li; Zhengtu Cong; Ru He; Gang Zhu
Journal:  Indian J Psychiatry       Date:  2022-03-24       Impact factor: 1.759

Review 4.  The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy.

Authors:  Hui-Min Liu; Le-le Ma; Chunyu Li; Bo Cao; Yifang Jiang; Li Han; Runchun Xu; Junzhi Lin; Dingkun Zhang
Journal:  Transl Oncol       Date:  2021-12-04       Impact factor: 4.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.